Sarah N. Larson

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington’s disease

A. Araque, J. Lucas, G. Öz, 2022, Acta neuropathologica communications.

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington’s disease

A. Araque, J. Lucas, G. Öz, 2020, bioRxiv.

Long‐term behavioral effects observed in mice chronically exposed to static ultra‐high magnetic fields

G. Metzger, K. Uğurbil, I. Tkáč, 2021, Magnetic resonance in medicine.

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease

J. Lucas, G. Öz, M. Benneyworth, 2022, Acta Neuropathologica Communications.

Protein kinase CK2 alpha prime and alpha-synuclein constitute a key regulatory pathway in Huntington’s disease

A. Araque, G. Öz, M. Benneyworth, 2020 .

Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.

H. Zoghbi, H. Orr, G. Öz, 2018, JCI insight.

Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.

H. Zoghbi, H. Orr, G. Öz, 2018, JCI insight.